24小时热门版块排行榜    

查看: 9120  |  回复: 27
当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖

Master-Fandy

铜虫 (小有名气)

[交流] 论文大修后,投稿状态从with editor直接变成decision in process,神马情况…… 已有23人参与

各位虫友,大家好!
小妹前段时间投了一篇论文,一个多月收到一审意见——大修,大概花了两个星期的时间,该补的理论实验也补充了,个人感觉整体上满足了审稿人的要求。9月1日返修回去,当天状态就变成with editor,3天后状态直接变成decision in process,好像没有经过under review过程。麻烦各位虫友们,帮忙分析一下具体情况和原因,自己都莫名的恐慌和紧张……目前还没收到任何结果。

另附审稿意见如下:
Reviewer #1: Ursolic acid(UA), the derivative of oleanolic acid, is widely studied due to numerous pharmacological activities. The author had synthesized a series of ursolic acid derivatives, which is a break ground result. In this paper, simulation approach is employed to explore the effects of binding affinity for inhibitory activities, which is an innovative work for the study on anti-diabetic properties of the hydrolyzation analogues of UA.
While, in order to verify that simulation model can explain the experimental results, some work needs to be complemented
Major Issues:
1. In the section of “structure activity relationship”
The author had got the value of IC50 by experiments, and calculated the binding energy to understand the relationship between binding mode and bioactivity. While Quantitative Structure-Activity and Relationships (QSAR) is the only persuasive tool to explain which structures play the important role in enhancing the inhibition activity.
In order to increase the confidence level of simulation results, the author has to demonstrate the QSAR equations to support their conclusions. The math expression of QSAR equation can be obtained by regression analysis. Only after the regression analysis work is completed, we can know which site in UA plays the important role for inhibition activity.
2. In the section of “molecular docking mode”, the author only listed the calculation results, but no parameter settings. The author has to list the major parameters, such as which kind of force field, which algorithm were used
Minor Issues:
3. Typo: In Figure 1. 3a - 8a & 3b – 8b should be replaced by 3a - 10a & 3b – 10b
4. Use idiomatic English expression:
Line 1: November 14 ---> November 14th;
Line 29: Expose
5. Some abbreviate needs full name, such as: Line 92: DMSO

Reviewer #2: This manuscript reports the synthesis and evaluation of a group of ursolic acid derivatives for anti-diabetic applications. The authors presented in vitro anti-diabetic activity and modeling studies to demonstrate their structure-bioactivity relationships, which would be useful for developing more effective alpha-glucosidase inhibitors. The manuscript is also well-written. I would recommend an acceptance in PLOS One after minor revisions.
1. The authors need to discuss what are the rationals of the overall molecular structure design and what are the objectives and hypotheses between each group analysis for molecules of interest.
2. It would be helpful if the authors can briefly discuss about the control (Acarbose) selection, since there are so many available inhibitors out there.
3. In the caption of Fig. 4, "liphilic" should be "Lipophilic". The authors need to carefully check over the manuscript to avoid typos.
回复此楼

» 猜你喜欢

» 本主题相关价值贴推荐,对您同样有帮助:

身体是革命的本钱,拼搏是永恒的主题!
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

幸福の味道

新虫 (小有名气)


小木虫: 金币+0.5, 给个红包,谢谢回帖
应该是无需返给审稿人,编辑直接决定。中的机会很大,提前恭喜你啦

[ 发自手机版 https://muchong.com/3g ]
3楼2015-09-04 22:25:27
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
查看全部 28 个回答

sunnyboy555

至尊木虫 (知名作家)


小木虫: 金币+0.5, 给个红包,谢谢回帖
正常,应该是编辑直接做决定了,我上一篇也是这样,很快Accept

[ 发自小木虫客户端 ]
2楼2015-09-04 22:16:21
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

cjinfor

铁杆木虫 (文坛精英)

应该马上要接受

[ 发自手机版 https://muchong.com/3g ]
4楼2015-09-04 22:29:33
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

Master-Fandy

铜虫 (小有名气)

引用回帖:
2楼: Originally posted by sunnyboy555 at 2015-09-04 22:16:21
正常,应该是编辑直接做决定了,我上一篇也是这样,很快Accept

感谢吉言,希望可以顺利吧!
身体是革命的本钱,拼搏是永恒的主题!
5楼2015-09-05 00:11:31
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
普通表情 高级回复 (可上传附件)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[考研] 299求调剂 +4 shxchem 2026-03-20 5/250 2026-03-21 00:24 by 星空星月
[考研] 296求调剂 +6 www_q 2026-03-18 10/500 2026-03-20 23:56 by JourneyLucky
[考研] 考研调剂求学校推荐 +3 伯乐29 2026-03-18 5/250 2026-03-20 22:59 by JourneyLucky
[考研] 一志愿中南化学(0703)总分337求调剂 +8 niko- 2026-03-19 9/450 2026-03-20 21:57 by luoyongfeng
[考研] 一志愿西南交通 专硕 材料355 本科双非 求调剂 +5 西南交通专材355 2026-03-19 5/250 2026-03-20 21:10 by JourneyLucky
[考研] 一志愿吉林大学材料学硕321求调剂 +11 Ymlll 2026-03-18 15/750 2026-03-20 19:40 by 丁丁*
[考研] 一志愿南理工085701环境302求调剂院校 +3 葵梓卫队 2026-03-20 3/150 2026-03-20 19:28 by zhukairuo
[考研] 复试调剂 +4 z1z2z3879 2026-03-14 6/300 2026-03-19 17:18 by fei626-918
[考研] 0703化学 305求调剂 +4 FY_yy 2026-03-14 4/200 2026-03-19 05:54 by anny19840123
[考研] 312求调剂 +8 陌宸希 2026-03-16 9/450 2026-03-18 12:39 by Linda Hu
[考研] 268求调剂 +6 简单点0 2026-03-17 6/300 2026-03-18 09:04 by 无际的草原
[考研] 278求调剂 +5 烟火先于春 2026-03-17 5/250 2026-03-18 08:43 by 星空星月
[考研] 一志愿苏州大学材料工程(085601)专硕有科研经历三项国奖两个实用型专利一项省级立项 +6 大火山小火山 2026-03-16 8/400 2026-03-17 15:05 by 无懈可击111
[考博] 26申博 +4 八6八68 2026-03-16 4/200 2026-03-17 13:00 by 轻松不少随
[考研] 考研调剂 +3 淇ya_~ 2026-03-17 5/250 2026-03-17 09:25 by Winj1e
[考研] 一志愿,福州大学材料专硕339分求调剂 +3 木子momo青争 2026-03-15 3/150 2026-03-17 07:52 by laoshidan
[基金申请] 今年的国基金是打分制吗? 50+3 zhanghaozhu 2026-03-14 3/150 2026-03-16 17:07 by 北京莱茵润色
[考研] 304求调剂 +4 ahbd 2026-03-14 4/200 2026-03-16 16:48 by 我的船我的海
[考研] 321求调剂 +5 大米饭! 2026-03-15 5/250 2026-03-16 16:33 by houyaoxu
[考研] 070300化学学硕求调剂 +6 太想进步了0608 2026-03-16 6/300 2026-03-16 16:13 by kykm678
信息提示
请填处理意见